Morgan Stanley’s Forecast Proven Right as Eli Lilly Stock Hits Impressive $740 Milestone
Leading pharmaceutical company Eli Lilly and Company witnessed a significant surge in its stock price, reaching a new all-time high of $740 per share, according to recent reports. This development has prompted analysts at Morgan Stanley to provide insights into the future prospects of the company.